Anne Chun Longo

Anne Chun Longo is Co-Founder of PharmatrophiX and served as its Founding CEO from 2006 to 2025. She currently serves as Senior Advisor, continuing to advance the company’s mission to develop novel therapeutics for neurodegenerative diseases.

She brings more than 25 years of experience in academic medicine and development, most recently at Stanford University, where she leads strategic initiatives to secure philanthropic funding for innovative clinical programs and translational research in the neurosciences and cancer, raising more than $360 million, including the creation of 14 endowed professorships.

Throughout her career, Ms. Longo has partnered with physician-scientists, institutional leaders, donors, and investors to align funding with high-impact research priorities. She has deep experience bridging philanthropy, academic medicine, and early-stage science—helping translate promising research into funded programs and clinical impact.

At PharmatrophiX, she manages business development, investor relations, and patient advocacy efforts, with a focus on accelerating therapies that address significant unmet needs in neurodegenerative disorders.

She holds a bachelor’s degree from Stanford University.